This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 19-21, 2024
Pre-Conference Workshops on March 18, 2024Philadelphia Marriott Downtown | Philadelphia, PA

Kory Hallett
Senior Director, Business Development Search and Evaluation at Otsuka Pharmaceuticals


Kory is Sr. Director for Business Development, Search and Evaluation at Otsuka America Pharmaceutical Inc where she leads efforts to build Otsuka’s rare disease portfolio through external innovation. An immunologist by training with over a decade of experience, Kory’s main focus at Otsuka is therapeutics for rare autoimmune diseases. Prior to Otsuka, Kory spent 8 years at the National Cancer Institute in the Small Business Innovation Research office, a non-dilutive seed investment program to support US startup companies in biotech and pharma.

Agenda Sessions

  • Investor Panel – Unlocking Rare Disease Investment Success through Valuation, Risk, and Innovation